CL2021001441A1 - Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos (divisional de la solicitud no. 201802932) - Google Patents
Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos (divisional de la solicitud no. 201802932)Info
- Publication number
- CL2021001441A1 CL2021001441A1 CL2021001441A CL2021001441A CL2021001441A1 CL 2021001441 A1 CL2021001441 A1 CL 2021001441A1 CL 2021001441 A CL2021001441 A CL 2021001441A CL 2021001441 A CL2021001441 A CL 2021001441A CL 2021001441 A1 CL2021001441 A1 CL 2021001441A1
- Authority
- CL
- Chile
- Prior art keywords
- divisional
- antibodies
- compositions
- methods
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662322770P | 2016-04-14 | 2016-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2021001441A1 true CL2021001441A1 (es) | 2021-11-19 |
Family
ID=58671580
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018002932A CL2018002932A1 (es) | 2016-04-14 | 2018-10-12 | Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos. |
| CL2021001441A CL2021001441A1 (es) | 2016-04-14 | 2021-06-02 | Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos (divisional de la solicitud no. 201802932) |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018002932A CL2018002932A1 (es) | 2016-04-14 | 2018-10-12 | Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10973897B2 (es) |
| EP (1) | EP3442569A1 (es) |
| JP (1) | JP2019513797A (es) |
| KR (1) | KR20190039022A (es) |
| CN (2) | CN116059330A (es) |
| AU (1) | AU2017248680A1 (es) |
| BR (1) | BR112018071108A2 (es) |
| CA (1) | CA3020856A1 (es) |
| CL (2) | CL2018002932A1 (es) |
| CO (1) | CO2018012295A2 (es) |
| CU (1) | CU20180127A7 (es) |
| EC (1) | ECSP18079073A (es) |
| MX (1) | MX2018012504A (es) |
| NI (1) | NI201800105A (es) |
| PE (1) | PE20190104A1 (es) |
| RU (1) | RU2018139865A (es) |
| SG (1) | SG11201808915YA (es) |
| WO (1) | WO2017178660A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2594637B (en) * | 2019-01-07 | 2023-08-02 | Genome Res Ltd | Novel trypanosomal vaccine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2731370A1 (de) * | 1977-07-12 | 1979-01-25 | Behringwerke Ag | Chagas impfstoff und verfahren zu dessen herstellung |
| ES2169995B1 (es) | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
| US20040057958A1 (en) | 2002-05-17 | 2004-03-25 | Waggoner David W. | Immunogenicity-enhancing carriers and compositions thereof and methods of using the same |
| SA110310855B1 (ar) * | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| US9804158B2 (en) | 2013-07-02 | 2017-10-31 | Institut De Recherche Pour Le Développement | Peptides and methods for the detection of Leishmaniasis |
| US9566320B2 (en) | 2013-09-24 | 2017-02-14 | The Board Of Regents Of The University Of Texas System | Mucin-associated surface protein as vaccine against Chagas disease |
-
2017
- 2017-04-14 US US15/487,935 patent/US10973897B2/en active Active
- 2017-04-18 SG SG11201808915YA patent/SG11201808915YA/en unknown
- 2017-04-18 RU RU2018139865A patent/RU2018139865A/ru not_active Application Discontinuation
- 2017-04-18 EP EP17721544.9A patent/EP3442569A1/en active Pending
- 2017-04-18 CN CN202211370674.1A patent/CN116059330A/zh active Pending
- 2017-04-18 WO PCT/EP2017/059189 patent/WO2017178660A1/en active Application Filing
- 2017-04-18 CU CU2018000127A patent/CU20180127A7/es unknown
- 2017-04-18 KR KR1020187032828A patent/KR20190039022A/ko unknown
- 2017-04-18 JP JP2018554466A patent/JP2019513797A/ja active Pending
- 2017-04-18 PE PE2018001985A patent/PE20190104A1/es not_active Application Discontinuation
- 2017-04-18 BR BR112018071108-0A patent/BR112018071108A2/pt not_active Application Discontinuation
- 2017-04-18 CN CN201780037260.8A patent/CN109310747B/zh active Active
- 2017-04-18 MX MX2018012504A patent/MX2018012504A/es unknown
- 2017-04-18 AU AU2017248680A patent/AU2017248680A1/en not_active Abandoned
- 2017-04-18 CA CA3020856A patent/CA3020856A1/en active Pending
-
2018
- 2018-10-12 NI NI201800105A patent/NI201800105A/es unknown
- 2018-10-12 CL CL2018002932A patent/CL2018002932A1/es unknown
- 2018-10-19 EC ECSENADI201879073A patent/ECSP18079073A/es unknown
- 2018-11-14 CO CONC2018/0012295A patent/CO2018012295A2/es unknown
-
2021
- 2021-04-03 US US17/221,788 patent/US20210220453A1/en active Pending
- 2021-06-02 CL CL2021001441A patent/CL2021001441A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116059330A (zh) | 2023-05-05 |
| AU2017248680A1 (en) | 2018-11-22 |
| ECSP18079073A (es) | 2019-02-28 |
| EP3442569A1 (en) | 2019-02-20 |
| WO2017178660A1 (en) | 2017-10-19 |
| CN109310747A (zh) | 2019-02-05 |
| MX2018012504A (es) | 2019-08-29 |
| CA3020856A1 (en) | 2017-10-19 |
| JP2019513797A (ja) | 2019-05-30 |
| PE20190104A1 (es) | 2019-01-15 |
| BR112018071108A2 (pt) | 2019-02-26 |
| WO2017178660A9 (en) | 2017-12-07 |
| CU20180127A7 (es) | 2019-08-06 |
| US20210220453A1 (en) | 2021-07-22 |
| SG11201808915YA (en) | 2018-11-29 |
| NI201800105A (es) | 2019-02-18 |
| US10973897B2 (en) | 2021-04-13 |
| US20170296637A1 (en) | 2017-10-19 |
| CL2018002932A1 (es) | 2019-02-01 |
| KR20190039022A (ko) | 2019-04-10 |
| CN109310747B (zh) | 2022-11-22 |
| CO2018012295A2 (es) | 2019-04-30 |
| RU2018139865A (ru) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018011804A2 (es) | Receptores quiméricos de flt3 y métodos de uso de los mismos | |
| CL2020001048A1 (es) | Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281) | |
| CO2020006900A2 (es) | Medios y método para preparar vectores virales y usos de los mismos | |
| CL2019003627A1 (es) | Anticuerpos anti-pd-1 y sus usos. (solicitud divisional 201900628) | |
| DOP2019000165A (es) | Anticuerpos anti-ox40 y sus usos | |
| BR112019012343A2 (pt) | anticorpos il-11ra | |
| CY1124806T1 (el) | Αντισωματα enanti-cd40 και χρησεις αυτων | |
| DK3408295T3 (da) | Farmaceutisk sammensætning, som omfatter bispecifikke antistofkonstruktioner | |
| CL2023000896A1 (es) | Receptores quiméricos de dll3 y métodos para su uso | |
| CU20180062A7 (es) | Anticuerpos neutralizadores del virus de inmunodeficiencia humana | |
| TR201901445T4 (tr) | Il2rbeta/yaygın gamma zinciri antikorları. | |
| CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
| CL2018002543A1 (es) | Anticuerpos gitr, metodos y usos. | |
| CL2018001837A1 (es) | Compuestos antiproliferativos y sus composiciones farmacéuticas y usos | |
| WO2018075692A3 (en) | ANTIBODY CONSTRUCTIONS | |
| CL2016002089A1 (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| BR112017020374A2 (pt) | compostos bicíclicos fundidos para o tratamento de doença | |
| CL2021001441A1 (es) | Antígenos y anticuerpos de chagas y composiciones, métodos y usos de los mismos (divisional de la solicitud no. 201802932) | |
| EA201892376A1 (ru) | Комбинированный состав трех противовирусных соединений | |
| EA201991319A1 (ru) | Вакцины аттенуированного свиного гриппа и способы их изготовления и применения | |
| EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| TR201820430T4 (tr) | Yeni fosfinan ve azafosfinan türevleri, bunların hazırlanış yöntemi ve bunları içeren farmasötik terkipler. | |
| CL2021002836A1 (es) | Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos (divisional de la solicitud n° 201900424) | |
| AR111011A1 (es) | Poxvirus quiméricos sintéticos | |
| ES2722574R1 (es) | Proceso para la preparación de 9beta,10alfa-progesterona (retroprogesterona) |